Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
The CSL Ltd (ASX:CSL) share price is lower 2.3% since the start of the 2024. It’s probably worth asking, ‘is the CSL share price priced to perfection?’
The Resmed CDI (ASX:RMD) share price has increased 7.0% since the start of the 2024. It’s probably worth asking, ‘is the RMD share price priced to perfection?’
The CSL Ltd (ASX:CSL) share price is lower 3.0% since the start of the 2024. It’s probably worth asking, ‘is the CSL share price undervalued?’
Resmed Inc (ASX: RMD) reported Q3 earnings overnight, on Thursday 25 April, sending RMD shares in its US up +11% after-hours.
The Resmed (ASX:RMD) share price has climbed 7% after the ASX healthcare share revealed its performance for the three months to March 2024.
The Resmed CDI (ASX:RMD) share price is lower 5.6% since the start of the 2024. It’s probably worth asking, ‘is the RMD share price undervalued?’
The CSL Ltd (ASX:CSL) share price is lower 1.0% since the start of the 2024. It’s probably worth asking, ‘is the CSL share price priced to perfection?’
The Resmed CDI (ASX:RMD) share price is lower 8.3% since the start of the 2024. It’s probably worth asking, ‘is the RMD share price priced to perfection?’
The CSL Ltd (ASX:CSL) share price is lower 4.4% since the start of the 2024. It’s probably worth asking, ‘is the CSL share price undervalued?’
